Rationale, design and methodology of a double-blind, randomized, placebo-controlled study of escitalopram in prevention of Depression in Acute Coronary Syndrome (DECARD)

被引：0
|
作者：
Baiba Hedegaard Hansen
Jamal Abed Hanash
Alice Rasmussen
Jørgen Fischer Hansen
Morten Birket-Smith
机构：
[1] Bispebjerg University Hospital,Liaison Psychiatry Unit, Psychiatric Centre Bispebjerg
[2] Bispebjerg University Hospital,Department of Cardiology
[3] University Hospital of Copenhagen Rigshospitalet,Department of Psychiatry
来源：
Trials | / 10卷
关键词：
Percutaneous Coronary Intervention; Acute Coronary Syndrome; Heart Rate Variability; Selective Serotonin Reuptake Inhibitor; Escitalopram;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Rationale, design and methodology of a double-blind, randomized, placebo-controlled study of escitalopram in prevention of Depression in Acute Coronary Syndrome (DECARD)
    Hansen, Baiba Hedegaard
    Hanash, Jamal Abed
    Rasmussen, Alice
    Hansen, Jorgen Fischer
    Birket-Smith, Morten
    TRIALS, 2009, 10
  • [2] A double-blind, randomized, placebo-controlled trial of escitalopram in the treatment of pediatric depression
    Wagner, KD
    Jonas, J
    Findling, RL
    Ventura, D
    Saikali, K
    JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2006, 45 (03) : 280 - 288
  • [3] Effects of escitalopram in prevention of depression in patients with acute coronary syndrome (DECARD)
    Hansen, Baiba Hedegaard
    Hanash, Jamal Abed
    Rasmussen, Alice
    Hansen, Jorgen Fischer
    Andersen, Nadia Lyhne Traerup
    Nielsen, Olav Wendelboe
    Birket-Smith, Morten
    JOURNAL OF PSYCHOSOMATIC RESEARCH, 2012, 72 (01) : 11 - 16
  • [4] Fluvastatin in the therapy of acute coronary syndrome: Rationale and design of a multicenter, randomized, double-blind, placebo-controlled trial (The FACS Trial)[ISRCTN81331696]
    Petr Ostadal
    David Alan
    Petr Hajek
    Jiri Vejvoda
    Martin Mates
    Peter Blasko
    Josef Veselka
    Milan Kvapil
    Jiri Kettner
    Martin Wiendl
    Ondrej Aschermann
    Josef Slaby
    Eduard Nemecek
    Frantisek Holm
    Marek Rac
    Milan Macek
    Jana Cepova
    Current Controlled Trials in Cardiovascular Medicine, 2005, 6
  • [5] A randomized, double-blind, placebo-controlled study of escitalopram in patients with social anxiety disorder in Japan
    Asakura, Satoshi
    Hayano, Taiji
    Hagino, Atsushi
    Koyama, Tsukasa
    CURRENT MEDICAL RESEARCH AND OPINION, 2016, 32 (04) : 749 - 757
  • [6] The efficacy of escitalopram in major depressive disorder: a multicenter randomized, placebo-controlled double-blind study
    Wang, Xiaoliang
    Fan, Yimin
    Li, Guanjun
    Li, Huafang
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2021, 36 (03) : 133 - 139
  • [7] A Randomized, Double-Blind, Placebo-Controlled Trial of Escitalopram in Patients with Asthma and Major Depressive Disorder
    Brown, E. Sherwood
    Sayed, Nasreen
    Van Enkevort, Erin
    Kulikova, Alexandra
    Nakamura, Alyson
    Khan, David A.
    Ivleva, Elena I.
    Sunderajan, Prabha
    Bender, Bruce G.
    Holmes, Traci
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2018, 6 (05) : 1604 - 1612
  • [8] Pharmacotherapy Relapse Prevention with Escitalopram in Body Dysmorphic Disorder: A Double-Blind Placebo-Controlled Trial
    Phillips, Katharine
    Kesheviah, Aparna
    Dougherty, Darin
    Stout, Robert
    Menard, William
    Wilhelm, Sabine
    NEUROPSYCHOPHARMACOLOGY, 2015, 40 : S119 - S119
  • [9] Escitalopram in the treatment of multisomatoform disorder: a double-blind, placebo-controlled trial
    Muller, Jacqueline E.
    Wentzel, Ignatius
    Koen, Liezl
    Niehaus, Dana J. H.
    Seedat, Soraya
    Stein, Dan J.
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2008, 23 (01) : 43 - 48
  • [10] Efficacy and safety of Tongxin formula after stent implantation for acute coronary syndrome: A multicenter, double-blind, placebo-controlled randomized trial
    Zhu, Wen
    Zhang, Lei
    Xie, Feng-Qun
    Cheng, Jie
    Li, Xian-Kai
    Chen, Wei
    Yan, Shi-Yun
    Feng, Qi-Mao
    EXPLORE-THE JOURNAL OF SCIENCE AND HEALING, 2024, 20 (05)
12345